Kevin has 25+ years’ experience in the public sector and biopharmaceutical industry, predominately in European Corporate Affairs. His passion for patient centred decision-making and building trusting relationships has made him instrumental in the creation of impactful public health campaigns in rare diseases, oncology, cardiovascular disease and paediatric medicines. As VP, Corporate Affairs, Worldwide Markets, at Celgene, from 2007 to 2019, Kevin built a fully integrated Corporate Affairs community of 80 professionals across the globe that encompassed external and internal communications, government relations and patient advocacy. Kevin and his team were instrumental in shaping European laws, building trusting relationships with the patient community and delivering ground-breaking communication campaigns.